Skip to main content
OMER
NASDAQ Life Sciences

Omeros Posts $57.4M Third-Quarter Loss

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$17.532
Mkt Cap
$1.207B
52W Low
$6.59
52W High
$21.24
52W Position info
166% above low
Off High info
17% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

OMER has more than doubled off its 52-week low of $6.59.

Summary

Omeros reported a $57.4 million loss for the third quarter, or 79 cents a share, a sharp swing from the positive net income the company posted in Q2, when YARTEMLEA sales were surging. YARTEMLEA net revenue rose 26% in the quarter. The reversal matters because the bull case has rested on commercial traction for YARTEMLEA plus debt buybacks that were meant to curb dilution. A quarter this deep in the red raises the question of whether the Q2 profit was a one-off and how much cash the launch is actually consuming. The stock trades near $17.53 with a market cap around $1.2 billion, so a loss of this size is material relative to the equity base. Note the October 30 8-K granting CEO Gregory Demopulos up to 500,000 options at $17.88 that vest only on a much higher stock price — management is aligned to a recovery.

At the time of this announcement, OMER was trading at $17.53 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $6.59 to $21.24. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

OMER - Latest Insights

OMER
Nov 16, 2026, 4:11 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $15.00
Real-time Price: $15.79 info
Change: +$0.7942 (+5%) info
Market Cap: $1.207B info
OMER
Oct 16, 2026, 6:19 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $17.05
Real-time Price: $15.79 info
Change: -$1.26 (-7%) info
Market Cap: $1.207B info
OMER
Aug 12, 2026, 4:12 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $16.11
Real-time Price: $15.79 info
Change: -$0.320 (-2%) info
Market Cap: $1.207B info
OMER
Aug 12, 2026, 4:10 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $15.60
Real-time Price: $15.79 info
Change: +$0.190 (+1%) info
Market Cap: $1.207B info
OMER
Aug 03, 2026, 8:30 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $12.00
Real-time Price: $15.79 info
Change: +$3.79 (+32%) info
Market Cap: $1.207B info